At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Continuous Glucose Monitoring in Subjects With Type 2 Diabetes
Rocky Mountain Diabetes and Osteoporosis Center·observational·Posted Apr 25, 2011·Updated May 2, 2014
In Brief
An observational study for Type 2 Diabetes Mellitus. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ability to manage their diabetes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
First PostedApr 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedApr 25, 2011
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.2 years ago